Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lymphoma
Biotech
Nkarta continues pivot to lupus by shelving lymphoma program
Nkarta’s pivot from oncology to autoimmune disease has continued with the biotech halting work on its CAR NK in lymphoma to focus on lupus.
James Waldron
Nov 8, 2024 8:55am
Viracta begins 2nd round of layoffs in 3 months
Nov 7, 2024 5:02am
Viracta axes staff to slim down for race to cancer finish line
Aug 14, 2024 8:09am
FDA blocks approval of Regeneron's blood cancer drug
Mar 25, 2024 9:25pm
Innate drops monotherapy plans for lacutamab in type of lymphoma
Mar 21, 2024 8:27am
Allogene stops pivotal trials, pursues first-line CAR-T cures
Jan 5, 2024 8:55am
